Justices Won't Review Doc's Conviction For Drug Trial Trades
The U.S. Supreme Court won't rethink a Connecticut cardiologist's conviction for trading a biotech company's stock based on nonpublic clinical trial information, rejecting on Monday a petition that drew support from billionaire...To view the full article, register now.
Already a subscriber? Click here to view full article